Yes a complete overreaction.
We got smashed early in the week with the fears of a US recession, then further smashed after the trial results along with our great Angleman results.
it is hard to watch but to be frank I’m in until a buyout so I am just biding time until that occurs.
My main fear is that market makers are pushing this down to reduce any buyout figure, but I trust Jon knows what we have and what it’s worth, hence the speak of taking 2 indications through to ph3 if BP don’t offer fair value for our “platform” drug.
Just have to work longer than I wanted. Such is life…,
That may be considered a selfish view as I do want this drug to be in the hands of those that need it ASAP, but I’ve been here a long time and would like closure on this.
NEU has been completely de-risked at this point...., page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.70 |
Change
-0.310(2.38%) |
Mkt cap ! $1.623B | |||
| Open | High | Low | Value | Volume |
| $12.80 | $12.90 | $12.69 | $5.154M | 403.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4631 | $12.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.76 | 1060 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |